Effect of cTBS on Startle and TMS-evoked BOLD
NCT: NCT07415772 · NOT_YET_RECRUITING
Brief Summary
The right dorsolateral prefrontal cortex (dlPFC) is increasingly being targeted with transcranial magnetic stimulation (TMS) to reduce anxiety expression; however, there is little mechanistic evidence supporting an optimized treatment protocol. Thus, the objective of the current project is to develop an interleaved TMS/fMRI that can assess the effect of neuromodulatory (potentially therapeutic) TMS protocols on neural and behavioral measures related to anxiety expression. PUBLIC HEALTH RELEVANCE: These results will yield direct evidence that 1 Hz and cTBS modulate brain activity associated with anxiety expression and regulation, thus informing novel TMS based anxiety treatments.
Frequently Asked Questions
What is Effect of cTBS on Startle and TMS-evoked BOLD?
Effect of cTBS on Startle and TMS-evoked BOLD is a clinical trial registered under NCT07415772. Current status: NOT_YET_RECRUITING.
What is the status of NCT07415772?
The current status of NCT07415772 (Effect of cTBS on Startle and TMS-evoked BOLD) is: NOT_YET_RECRUITING.
When did Effect of cTBS on Startle and TMS-evoked BOLD start?
Effect of cTBS on Startle and TMS-evoked BOLD started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.